| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
[description not available] | 0 | 2.31 | 1 | 0 |
Diffuse Mixed Small and Large Cell Lymphoma
[description not available] | 0 | 2.31 | 1 | 0 |
Lymphoma, Non-Hodgkin
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. | 0 | 2.31 | 1 | 0 |
Lymphoma, Mantle-Cell
A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1). | 0 | 2.31 | 1 | 0 |
Fatty Liver with Encephalopathy
[description not available] | 0 | 2.4 | 2 | 0 |
Ache
[description not available] | 0 | 2.06 | 1 | 0 |
Pain
An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. | 1 | 4.06 | 1 | 0 |
Poisoning
Used with drugs, chemicals, and industrial materials for human or animal poisoning, acute or chronic, whether the poisoning is accidental, occupational, suicidal, by medication error, or by environmental exposure. | 0 | 2.06 | 1 | 0 |
Adverse Drug Event
[description not available] | 0 | 3.46 | 1 | 1 |
Middle Ear Inflammation
[description not available] | 0 | 3.46 | 1 | 1 |
Otitis Media
Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. | 0 | 3.46 | 1 | 1 |
Drug-Related Side Effects and Adverse Reactions
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. | 0 | 3.46 | 1 | 1 |
Innate Inflammatory Response
[description not available] | 0 | 2.35 | 2 | 0 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 2.35 | 2 | 0 |
Polyarthritis
[description not available] | 0 | 2.34 | 2 | 0 |
Arthritis
Acute or chronic inflammation of JOINTS. | 0 | 2.34 | 2 | 0 |
Acute Rheumatic Fever
[description not available] | 0 | 1.93 | 1 | 0 |
Rheumatism
[description not available] | 0 | 1.93 | 1 | 0 |
Rheumatic Diseases
Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. | 0 | 6.93 | 1 | 0 |
Pyrexia
[description not available] | 0 | 2.87 | 1 | 0 |
Fever
An abnormal elevation of body temperature, usually as a result of a pathologic process. | 1 | 4.87 | 1 | 0 |
Rheumatoid Arthritis
[description not available] | 0 | 2.36 | 2 | 0 |
Arthritis, Rheumatoid
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. | 0 | 2.36 | 2 | 0 |
Chronic Illness
[description not available] | 0 | 3.38 | 1 | 1 |
Recrudescence
[description not available] | 0 | 3.38 | 1 | 1 |
Aphthae
[description not available] | 0 | 3.38 | 1 | 1 |
Gingivostomatitis, Herpetic
[description not available] | 0 | 3.38 | 1 | 1 |
Chronic Disease
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). | 0 | 3.38 | 1 | 1 |
Stomatitis, Aphthous
A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. (From Jablonski's Dictionary of Dentistry, 1992, p742) | 0 | 3.38 | 1 | 1 |
Stomatitis, Herpetic
Stomatitis caused by Herpesvirus hominis. It usually occurs as acute herpetic stomatitis (or gingivostomatitis), an oral manifestation of primary herpes simplex seen primarily in children and adolescents. | 0 | 3.38 | 1 | 1 |
Mouth Ulcer
[description not available] | 0 | 2 | 1 | 0 |
Burns, Chemical
Burns caused by contact with or exposure to CAUSTICS or strong ACIDS. | 0 | 2 | 1 | 0 |
Deficiency of Glucose-6-Phosphate Dehydrogenase
[description not available] | 0 | 2 | 1 | 0 |
Glucosephosphate Dehydrogenase Deficiency
A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia. | 0 | 2 | 1 | 0 |
Oral Ulcer
A loss of mucous substance of the mouth showing local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue. It is the result of a variety of causes, e.g., denture irritation, aphthous stomatitis (STOMATITIS, APHTHOUS); NOMA; necrotizing gingivitis (GINGIVITIS, NECROTIZING ULCERATIVE); TOOTHBRUSHING; and various irritants. (From Jablonski, Dictionary of Dentistry, 1992, p842) | 0 | 2 | 1 | 0 |
Craniofacial Pain
[description not available] | 0 | 3.84 | 1 | 0 |
Facial Pain
Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES. | 0 | 3.84 | 1 | 0 |
Atrial Septal Defect
[description not available] | 0 | 2.01 | 1 | 0 |
Mitral Stenosis
[description not available] | 0 | 2.01 | 1 | 0 |
Mouth Diseases
Diseases involving the MOUTH. | 0 | 2.39 | 2 | 0 |
Mitral Valve Stenosis
Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause. | 0 | 2.01 | 1 | 0 |
Alveolalgia
[description not available] | 0 | 1.95 | 1 | 0 |
Infection, Postoperative Wound
[description not available] | 0 | 1.95 | 1 | 0 |
Mucositis, Oral
[description not available] | 0 | 3.34 | 1 | 1 |
Gingivitis
Inflammation of gum tissue (GINGIVA) without loss of connective tissue. | 0 | 4.31 | 2 | 2 |
Stomatitis
INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP. | 0 | 3.34 | 1 | 1 |
Pericementitis
[description not available] | 0 | 1.96 | 1 | 0 |
Periodontitis
Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology) | 0 | 1.96 | 1 | 0 |
Asthma, Bronchial
[description not available] | 0 | 1.96 | 1 | 0 |
Bronchospasm
[description not available] | 0 | 1.96 | 1 | 0 |
Allergy, Drug
[description not available] | 0 | 1.96 | 1 | 0 |
Hives
[description not available] | 0 | 1.96 | 1 | 0 |
Asthma
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). | 0 | 1.96 | 1 | 0 |
Bronchial Spasm
Spasmodic contraction of the smooth muscle of the bronchi. | 0 | 1.96 | 1 | 0 |
Drug Hypersensitivity
Immunologically mediated adverse reactions to medicinal substances used legally or illegally. | 0 | 1.96 | 1 | 0 |
Nasal Polyps
Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations. | 0 | 1.96 | 1 | 0 |
Urticaria
A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. | 0 | 1.96 | 1 | 0 |
Endotoxin Shock
[description not available] | 0 | 1.96 | 1 | 0 |
Shock, Septic
Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. | 0 | 1.96 | 1 | 0 |